...
首页> 外文期刊>American journal of psychiatry >Issues for DSM-V: the limitations of field trials: a lesson from DSM-IV.
【24h】

Issues for DSM-V: the limitations of field trials: a lesson from DSM-IV.

机译:DSM-V的问题:现场试验的局限性:DSM-IV的教训。

获取原文
获取原文并翻译 | 示例

摘要

Alesson from DSM-IV is that field testing cannot always predict the rates of mental disorders once a diagnostic system enters general use. The most difficult but also most consequential purpose of field trials is to determine how new criteria sets will affect definitions of caseness and rates of diagnosis. Ironically, clearer wording may make diagnoses easier to use but also make them susceptible to overuse-especially in primary care and by patients, families, and teachers. This potential can be amplified by drug company marketing-not just to psychiatrists, but especially to pediatricians, primary care physicians, and now the general public. The risk of an artifactual increase in diagnoses is particularly high for disorders at the boundary of normality, such as mood and anxiety disorders. "Not otherwise specified" categories and dimensional ratings, in which there is no threshold for diagnosis,but rather a continuous scale, are at particularly high risk for increased identification of symptoms in otherwise normal people.
机译:DSM-IV的Alesson认为,一旦诊断系统开始普遍使用,现场测试不能总是预测精神障碍的发生率。现场试验的最困难但也是最重要的目的是确定新的标准集将如何影响病例和诊断率的定义。具有讽刺意味的是,更清晰的措词可能使诊断更易于使用,但也使它们易于过度使用,尤其是在初级保健以及患者,家庭和教师中。药品公司的市场营销不仅可以扩大到精神科医生,而且可以扩大到儿科医生,初级保健医生以及现在的公众,从而可以扩大这种潜力。对于正常性边界的疾病,例如情绪和焦虑症,诊断中人为增加的风险特别高。 “没有其他规定”的类别和尺寸等级(其中没有诊断阈值,而是连续的等级)在增加正常人群中症状识别的风险中特别高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号